UAE Neurovascular Devices Market Size & Outlook, 2025-2033

The neurovascular devices market in the UAE is expected to reach a projected revenue of US$ 107.6 million by 2033. A compound annual growth rate of 4.7% is expected of the UAE neurovascular devices market from 2025 to 2033.
Revenue, 2024 (US$M)
$71.0
Forecast, 2033 (US$M)
$107.6
CAGR, 2025 - 2033
4.7%
Report Coverage
UAE

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE neurovascular devices market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE neurovascular devices market highlights

  • The UAE neurovascular devices market generated a revenue of USD 71.0 million in 2024 and is expected to reach USD 107.6 million by 2033.
  • The UAE market is expected to grow at a CAGR of 4.7% from 2025 to 2033.
  • In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device type in 2024.
  • Trans Radial Access Devices is the most lucrative device type segment registering the fastest growth during the forecast period.


Neurovascular devices market data book summary

Market revenue in 2024USD 71.0 million
Market revenue in 2033USD 107.6 million
Growth rate4.7% (CAGR from 2025 to 2033)
Largest segmentCerebral embolization and aneurysm coiling devices
Fastest growing segmentTrans Radial Access Devices
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationCerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices
Key market players worldwideMedtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp, Acandis GmbH, Spiegelberg, Zylox


Other key industry trends

  • In terms of revenue, UAE accounted for 1.0% of the global neurovascular devices market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, South Africa neurovascular devices market is projected to lead the regional market in terms of revenue in 2033.
  • Kuwait is the fastest growing regional market in Middle East & Africa and is projected to reach USD 78.6 million by 2033.

Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 36.9% in 2024. Horizon Databook has segmented the UAE neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2021 to 2033.


The UAE neurovascular devices market is expected to witness moderate growth rate over the forecast period. Increasing incidence of acute ischemic stroke in the UAE is a major factor contributing to the market growth. 

According to a study published by Omnia Health in 2020, in the UAE, around 7,000 stroke admissions are recorded every year and 85.00% of the stroke cases are acute ischemic strokes. Such factors are expected to positively impact the market growth.

However, low adoption rate of technologically advanced products and lack of skilled professionals in the country may hinder the market growth over the forecast period. The UAE is facing a shortage of medical personnel. 

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Neurovascular Devices Market Companies

Name Profile # Employees HQ Website
Zylox View profile 501-1000 Hangzhou, Zhejiang, China, Asia http://www.zyloxmedical.com/
Acandis GmbH View profile 251-500 Pforzheim, Baden-Wurttemberg, Germany, Europe https://www.acandis.com/start-1-en
Spiegelberg View profile 11-50 Hamburg, Hamburg, Germany, Europe https://www.spiegelberg.de/en/
Penumbra Inc View profile 4200 One Penumbra Place, Alameda, CA, United States, 94502 https://www.penumbrainc.com
MicroPort Scientific Corp View profile 8230 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, China, People's Republic of, 201203 https://www.microport.com
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Integra Lifesciences Holdings Corp View profile 3946 1100 Campus Road, Princeton, NJ, United States, 08540 https://www.integralife.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

UAE neurovascular devices market size, by device type, 2021-2033 (US$M)

UAE Neurovascular Devices Market Outlook Share, 2024 & 2033 (US$M)

UAE neurovascular devices market size, by device type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online